Changes in medical treatment six months after risk stratification with HeartScore and coronary artery calcification scanning of healthy middle-aged subjects

Sørensen, Mette Hjortdal; Gerke, Oke; Lambrechtsen, Jess; Sand, Niels Peter Rønnow; Mols, Rikke Elmose; Thomassen, Anders; Larsen, Mogens Lytken; Mickley, Hans; Diederichsen, Axel Cosmus Pyndt

doi:10.1177/1741826711428063

Cited by 8 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These tools are based on demographic and clinical risk factors with a proven prognostic impact in population-based analysis. Although some authors were able to show that the risk stratification with SCORE leads to beneficial changes in medication during follow-up, others failed to find an association between the SCORE and coronary artery calcium [19,20]. Although some authors were able to show that the risk stratification with SCORE leads to beneficial changes in medication during follow-up, others failed to find an association between the SCORE and coronary artery calcium [19,20].…”

Section: Discussionmentioning

confidence: 99%

Low previous cardiovascular risk of patients with ST-elevation myocardial infarction

Rodrigues

Gonçalves

Costa

et al. 2017

Coronary Artery Disease

View full text Add to dashboard Cite

In a population of patients with STEMI as the first manifestation of CAD, the CV risk stratification with the SCORE risk charts, if calculated before the event, would classify as low risk more than two-thirds of the patients (71.4%) and only 3.5% would be classified as very high-risk patients. The high prevalence of low-risk patients indicates the current challenge of CV risk stratification, underlying the need for additional tools in primary prevention to better identify patients at risk.

show abstract